FTC

With Trump victorious, biotech industry’s focus turns to his plans for FDA, FTC
BioPharma Dive
Thu, 11/7/24 - 11:30 am
Donald Trump
biotech
FTC
FDA
Robert F Kennedy Jr.
Why pharma megamergers may become a relic of the past
Pharma Voice
Thu, 10/24/24 - 09:49 am
M&A
FTC
megamergers
Novo Holdings' $16.5B Catalent buyout in crosshairs as consumer groups ask FTC to block the deal
Fierce Pharma
Fri, 10/18/24 - 11:26 am
Novo Holdings
Catalent
FTC
M&A
CVS, UnitedHealth press for FTC Chair Khan to be removed from PBM lawsuit
The Hill
Wed, 10/9/24 - 09:09 pm
PBMs
UnitedHealth
CVS Caremark
FTC
Lina Khan
Express Scripts sues FTC over drug pricing report
Reuters
Tue, 09/17/24 - 11:01 am
Express Scripts
FTC
PBMs
legal
drug pricing
Patent thickets in federal government’s crosshairs as election 2024 looms
BioSpace
Wed, 08/28/24 - 11:57 am
patents
patent thickets
FTC
PTO
generics
biosimilars
2024 Presidential election
US judge strikes down Biden administration ban on worker 'noncompete' agreements
Reuters
Tue, 08/20/24 - 10:12 pm
FTC
noncompete agreements
Boston Scientific resubmits Silk Road merger filing, giving FTC more review time
Medtech Dive
Sun, 08/18/24 - 09:17 pm
Medtech
Boston Scientific
M&A
Silk Road Medical
FTC
PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating
Drug Channels
Tue, 07/16/24 - 12:01 pm
FTC
PBMs
FTC poised to sue drug middlemen over insulin prices
Axios
Fri, 07/12/24 - 11:30 am
FTC
PBMs
insulin
diabetes
drug pricing
legal
CVS Caremark
Express Scripts
OptumRx
FTC report finds PBM power has “dire consequences”
Pharmaphorum
Tue, 07/9/24 - 11:22 am
FTC
PBMs
supply chain
FTC opens investigation into Teva, escalating patent fight with pharma industry
Washington Post, DC
Mon, 07/1/24 - 10:02 pm
FTC
Teva Pharmaceutical
patents
inhalers
FTC Supports PTO Push for Patent Settlement Scrutiny, Better Antitrust Oversight
BioSpace
Thu, 06/20/24 - 11:25 am
FTC
patents
antitrust
FTC backs rule change that could expose anticompetitive drug patent deals
First Word Pharma
Tue, 06/18/24 - 08:00 pm
FTC
antitrust
patents
regulatory
FTC request may signal trouble for Novo/Catalent deal
Pharma Voice
Thu, 05/30/24 - 11:09 am
Novo Holdings
Catalent
FTC
M&A
Maze lands new partner for Pompe drug, after Sanofi pact came apart
BioPharma Dive
Fri, 05/10/24 - 11:29 am
Maze Therapeutics
Pompe disease
Shionogi
FTC
Sanofi
MZE001
FTC seeks more information on Novo Nordisk parent-Catalent deal
Reuters
Fri, 05/3/24 - 11:28 am
FTC
Novo Nordisk
Catalent
M&A
GSK defends itself—again—after senator argues it withdrew popular asthma med to dodge price caps and Medicaid rebates
Fierce Pharma
Fri, 05/3/24 - 11:26 am
GSK
FTC
patents
Senate
FTC crackdown on ‘bogus’ patents hits Novo’s Ozempic, GSK’s Trelegy Ellipta
Medical Marketing and Media
Fri, 05/3/24 - 11:10 am
FTC
patents
Orange Book
Novo Nordisk
Ozempic
GSK
Trelegy Ellipta
FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal
Reuters
Thu, 04/4/24 - 10:57 am
Boston Scientific
Medtech
FTC
M&A
Axonics

Pages